发明名称 |
Novel cytokine zcytor17 ligand |
摘要 |
There is provided the use of a polypeptide for the manufacture of a medicament for up-regulating IL-13RA2 gene expression in a mammal, wherein the polypeptide comprises a sequence of amino acid residues that is at least 90% identical to the sequence of amino acid residues of a polypeptide selected from: (a) a polypeptide comprising the amino acid sequence from residues 38 (Val) to 152 (Leu) as shown in SEQ ID NO:2; (b) a polypeptide comprising the amino acid sequence from residues 27 (Leu) to 164 (Thr) as shown in SEQ ID NO:2; (c) a polypeptide comprising the amino acid sequence from residues 24 (Ser) to 164 (Thr) as shown in SEQ ID NO:2; and (d) a polypeptide comprising the amino acid sequence from residues 1 (Met) to 164 (Thr) as shown in SEQ ID NO:2. |
申请公布号 |
AU2003225525(B2) |
申请公布日期 |
2008.07.24 |
申请号 |
AU20030225525 |
申请日期 |
2003.01.21 |
申请人 |
ZYMOGENETICS, INC. |
发明人 |
ANGELA K HAMMOND;JOSEPH L KUIJPER;JANE A GROSS;MARIA M DASOVICH;STACEY R DILLON;CINDY A SPRECHER;JULIA E NOVAK;FRANCIS J GRANT |
分类号 |
C07K14/00;G01N33/53;A61K;A61K38/00;A61K39/395;A61P1/02;A61P1/04;A61P7/00;A61P11/06;A61P15/08;A61P17/06;A61P19/02;A61P29/00;A61P31/04;A61P35/00;A61P37/02;A61P37/08;A61P43/00;C07K;C07K14/47;C07K14/52;C07K16/18;C07K16/24;C07K19/00;C12N;C12N5/078;C12N5/10;C12N15/09;C12N15/12;C12N15/19;C12N15/63;C12P21/00;C12P21/02;C12P21/08;C12Q1/68;G01N;G01N33/566 |
主分类号 |
C07K14/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|